FoxP3 Expression in Tumor-Infiltrating Lymphocytes as Potential Predictor of Response to Immune Checkpoint Inhibitors in Patients with Advanced Melanoma and Non-Small Cell Lung Cancer

FoxP3 Expression in Tumor-Infiltrating Lymphocytes as Potential Predictor of Response to Immune Checkpoint Inhibitors in Patients with Advanced Melanoma and Non-Small Cell Lung Cancer

Immune checkpoint inhibitors (ICI) are the main therapy currently used in advanced malignant melanoma (MM) and non-small cell lung cancer (NSCLC). Despite the wide variety of uses, the possibility of predicting ICI efficacy in these tumor types is scarce. The aim of our study was to find new predict...

Full description

Bibliographic Details
Main Authors: Peter Grell, Simona Borilova, Pavel Fabian, Iveta Selingerova, David Novak, Petr Muller, Igor Kiss, Rostislav Vyzula
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Cancers
Subjects:
immune checkpoint inhibitors
anti-tumor immunity
predictive biomarker
malignant melanoma
NSCLC
Online Access:https://www.mdpi.com/2072-6694/15/6/1901

Internet

https://www.mdpi.com/2072-6694/15/6/1901

Similar Items